Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Antineoplastic Protocols
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Antineoplastic Protocols
Tree Number(s)
E02.183.750
E02.319.077
N05.715.360.330.125.500
Unique ID
D024221
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D024221
Annotation
coord with
COMBINED MODALITY THERAPY
if pertinent
Scope Note
Clinical protocols used to inhibit the growth or spread of
NEOPLASMS
.
Entry Term(s)
Cancer Treatment Protocols
Previous Indexing
Antineoplastic Combined Chemotherapy Protocols (1983-2001)
Public MeSH Note
2002
History Note
2002
Date Established
2002/01/01
Date of Entry
2001/07/25
Revision Date
2018/06/30
Allowable Qualifiers
classification (CL)
standards (ST)
Therapeutics [E02]
Clinical Protocols [E02.183]
Antineoplastic Protocols [E02.183.750]
Antineoplastic Combined Chemotherapy Protocols [E02.183.750.500]
Standing Orders [E02.183.875]
Therapeutics [E02]
Drug Therapy [E02.319]
Antineoplastic Protocols [E02.319.077]
Antineoplastic Combined Chemotherapy Protocols [E02.319.077.500]
Chelation Therapy [E02.319.155]
Chemoprevention [E02.319.162]
Chemoradiotherapy [E02.319.164]
Chemotherapy, Adjuvant [E02.319.170]
Consolidation Chemotherapy [E02.319.218]
COVID-19 Drug Treatment [E02.319.231]
Deprescriptions [E02.319.243]
Drug Administration Routes [E02.319.267]
Drug Administration Schedule [E02.319.283]
Drug Delivery Systems [E02.319.300]
Drug Dosage Calculations [E02.319.305]
Drug Prescriptions [E02.319.307]
Drug Tapering [E02.319.309]
Drug Therapy, Combination [E02.319.310]
Drug Therapy, Computer-Assisted [E02.319.335]
Electrochemotherapy [E02.319.341]
Enema [E02.319.347]
Enzyme Therapy [E02.319.353]
Fluid Therapy [E02.319.360]
Home Infusion Therapy [E02.319.444]
Hormone Replacement Therapy [E02.319.452]
Inappropriate Prescribing [E02.319.490]
Induction Chemotherapy [E02.319.499]
Maintenance Chemotherapy [E02.319.509]
Medication Errors [E02.319.529]
Molecular Targeted Therapy [E02.319.574]
Nicotine Replacement Therapy [E02.319.597]
Opiate Substitution Treatment [E02.319.620]
Orthomolecular Therapy [E02.319.630]
Photochemotherapy [E02.319.685]
Pleurodesis [E02.319.694]
Polypharmacy [E02.319.698]
Premedication [E02.319.703]
Sclerotherapy [E02.319.805]
Self Administration [E02.319.890]
Self Medication [E02.319.900]
Thrombolytic Therapy [E02.319.913]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Epidemiologic Study Characteristics [N05.715.360.330]
Clinical Protocols [N05.715.360.330.125]
Antineoplastic Protocols [N05.715.360.330.125.500]
Clinical Trial Protocols as Topic [N05.715.360.330.125.625]
Standing Orders [N05.715.360.330.125.750]
Expand All
Collapse All
Antineoplastic Protocols
Preferred
Concept UI
M0369661
Scope Note
Clinical protocols used to inhibit the growth or spread of
NEOPLASMS
.
Terms
Antineoplastic Protocols
Preferred Term
Term UI
T424193
Date
09/15/2000
LexicalTag
NON
ThesaurusID
NLM (2002)
Cancer Treatment Protocols
Term UI
T420728
Date
08/03/2000
LexicalTag
NON
ThesaurusID
NLM (2002)
page delivered in 0.187s